Description:
Home Page: silexion.com
The Goldyne Savad Institute of Gene Therapy
Jerusalem,
9112001
Israel
Phone:
972 2 674 3430
Officers
| Name | Title |
|---|---|
| Mr. Ilan Hadar M.B.A. | MD & Chairman |
| Ms. Mirit Horenshtein Hadar | Exec. VP of Fin. Affairs |
| Dr. Mitchell Shirvan M.B.A., Ph.D. | Chief Scientific & Devel. Officer |
| Prof. Eithan Galun M.D. | Co-Founder, Chairman of Scientific Board and Director |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2024-08-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |